Virtual reality improves walking coordination
- Trial ID
- NCT07250672
- Official Title
- Examining the Effect of Action Observation Training Using Patient-Specific 3D Records in Parkinson's Patients
- Goal
- Virtual reality improves walking coordination
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Abant Izzet Baysal University
- Study Type
- INTERVENTIONAL
- Enrollment
- 24 participants
- Conditions
- Parkinson Disease, Virtual Reality, Action Obervation Training, Immersive Virtual Reality, 3d Recording
- Interventions
- Patient-Specific VR Action Observation Training, Healthy-Model VR Action Observation Training
Summary For Families
The goal is to help people with mild to moderate Parkinson's improve walking and everyday motor skills by strengthening the brain circuits that plan and mirror movement. The approach uses immersive virtual reality so you watch 3D recordings, either of your own movements or of a healthy model, to activate motor learning pathways and encourage smoother, more coordinated actions; this is a non-drug rehab method used alongside your usual antiparkinsonian medications, not a replacement for levodopa. The trial is looking for people aged 50 to 85 with Parkinson's at Hoehn and Yahr stage 3 or lower who can walk independently and are on stable antiparkinsonian meds, excluding those with other neurological disorders, recent medication changes, significant 3D vision problems, or pronounced simulator sickness.
Locations
- Abant Izzet Baysal University Faculty of Health Science, Bolu, Bolu, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Patient-Specific VR Action Observation Training. The goal is to help people with mild to moderate Parkinson's improve walking and everyday motor skills by strengthening the brain circuits that plan and mirror movement. The approach uses immersive virtual reality so you watch 3D recordings, either of your own movements or of a healthy model, to activate motor learning pathways and encourage smoother, more coordinated actions; this is a non-drug rehab method used alongside your usual antiparkinsonian medications, not a replacement for levodopa. The trial is looking for people aged 50 to 85 with Parkinson's at Hoehn and Yahr stage 3 or lower who can walk independently and are on stable antiparkinsonian meds, excluding those with other neurological disorders, recent medication changes, significant 3D vision problems, or pronounced simulator sickness.
- Who can participate?
- Participants must be between 50 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 7 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.